Skip to main content

Recent News

Team to study new gene associated with Parkinson’s disease

June 18, 2018

A multidisciplinary team of researchers at Purdue University and the University of Bordeaux in France has received a grant from The Michael J. Fox Foundation for Parkinson’s Disease to study a new gene associated with Parkinson’s disease, which was linked to the disease using novel big data methodologies.

Read More about "Team to study new gene associated with Parkinson’s disease"

Discovery Park's chief scientist addresses congressional committee in Peru

June 18, 2018

Discovery Park's tagline, "Where disciplines converge to solve global challenges," gains real-world application through international partnerships. Tomás Díaz de la Rubia, Discovery Park's chief scientist and executive director, spoke Tuesday (June 12) to members of Peru's Congress as part of one such partnership -- presenting the mission of Discovery Park and an overview of the Arequipa NEXUS Institute for food, energy, water and the environment.

Read More about "Discovery Park's chief scientist addresses congressional committee in Peru"

Purdue Foundry Investment Fund backs 3 emerging life science startups

June 18, 2018

Purdue Research Foundation’s Foundry Investment Fund (FIF) has recently invested a total of $750,000 in three emerging life science startups as partial matches to investments being made in them by institutional and other investors.

Read More about "Purdue Foundry Investment Fund backs 3 emerging life science startups"

New compound shown to be as effective as FDA-approved drugs against life-threatening infections; tests indicate it is less susceptible to resistance

June 15, 2018

“This is very exciting,” said Herman Sintim, drug discovery professor in Purdue’s Department of Chemistry. “We are not the first to report of a new molecular entity that killed these drug-resistant pathogens. But what is unique about the compound that we found is that when we tried to generate resistance in the lab, we couldn't.”

Read More about "New compound shown to be as effective as FDA-approved drugs against life-threatening infections; tests indicate it is less susceptible to resistance"

C4E faculty Laura Bowling discusses how climate shifts could hurt Indiana Corn

June 15, 2018

Purdue Center for the Environment faculty, Laura Bowling discusses how climate shifts could hurt Indiana corn in a segment on listener supported radio station, WMOT Roots Radio. Listen to a radio version of this story "A new study predicts the U.S. could lose nearly half of its corn by the end of the century due to climate. That could have detrimental effects in Indiana, the country’s fifth largest corn-producing state. Corn production in Indiana has been increasing for decades, largely because of advances in genetics. Still, Indiana stands to lose up to 30 percent of its corn yield by the 22nd century. That’s according to Laura Bowling, a professor in Purdue University’s agronomy department."

Read More about "C4E faculty Laura Bowling discusses how climate shifts could hurt Indiana Corn"

New compound shown to be as effective as FDA-approved drugs against life-threatening infections; tests indicate it is less susceptible to resistance

June 15, 2018

researchers have identified a new compound that in preliminary testing has shown itself to be as effective as antibiotics approved by the Food and Drug Administration to treat life-threatening infections while also appearing to be less susceptible to bacterial resistance.

Read More about "New compound shown to be as effective as FDA-approved drugs against life-threatening infections; tests indicate it is less susceptible to resistance"

Medical imaging technology detects vascular disorders, injuries in brain without invasive contrast agents

June 14, 2018

Purdue University researchers have developed an analytical imaging technology based on functional MRI for detecting and monitoring cerebral vascular disorders and injuries that does not require the use of contrast agents. The new imaging method focuses on tracking an intrinsic blood-related MRI signal, which has been shown to travel with the blood. The signal is used as a natural biomarker to assess blood flow in a patient. Congratulations to PIIN Member Yunjie Tong on this outstanding achievement!

Read More about "Medical imaging technology detects vascular disorders, injuries in brain without invasive contrast agents"

Purdue unveils multi-year, multi-departmental learning community

June 14, 2018

Although most Purdue learning communities are meant to help burgeoning young freshmen find their place in college, one new community will change the status quo. The Data Mine is a new community that upends all of the norms that learning communities usually adhere to.

Read More about "Purdue unveils multi-year, multi-departmental learning community "

Purdue Foundry Investment Fund backs 3 emerging life science startups with $750,000 to help transition to sustainability

June 14, 2018

Purdue Research Foundation’s Foundry Investment Fund (FIF) has recently invested a total of $750,000 in three emerging life science startups as partial matching investments made in them by institutional and other investors.

Read More about "Purdue Foundry Investment Fund backs 3 emerging life science startups with $750,000 to help transition to sustainability"

Team to study new gene associated with Parkinson’s disease

June 14, 2018

A multidisciplinary team of researchers at Purdue University and the University of Bordeaux in France has received a grant from The Michael J. Fox Foundation for Parkinson’s Disease to study a new gene associated with Parkinson’s disease, which was linked to the disease using novel big data methodologies. The findings from this research could potentially be used to design new therapies to slow neurodegeneration in the brains of patients with Parkinson’s disease and other related disorders. Jean-Christophe Rochet, professor of medicinal chemistry and molecular pharmacology at Purdue; Erwan Bezard, research director at the Institute of Neurodegenerative Diseases at the University of Bordeaux; Jason Cannon, associate professor of toxicology at Purdue; and Min Zhang, professor of statistics at Purdue, will study the neuroprotective effects of the new gene, known as NFE2L1, in Parkinson’s disease models. Their collaboration was helped by a nearly $107,000 grant from the organization named for the famous actor who has Parkinson’s.

Read More about "Team to study new gene associated with Parkinson’s disease"

Purdue University, West Lafayette, IN 47907 (765) 494-4600

© 2018 Purdue University | An equal access/equal opportunity university | Copyright Complaints | Maintained by the Office for Research and Partnerships

If you have trouble accessing this page because of a disability, please contact the Office for Research and Partnerships at evprp@purdue.edu.